Published 9 months ago • loading... • Updated 9 months ago

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

Dr. Andreas Wallnöfer joins the board of Optigo Biotherapeutics – the ophthalmology company pioneering next-gen treatments for retinal diseases....

6 Articles

TheIFP.ca

+5 Reposted by 5 other sources

Lean Left

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Optigo Biotherapeutics (“Optigo”), an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas Wallnöfer is joining its Board of Directors as the company advances its lead program…

9 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year